Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001015820-16-000077
Filing Date
2016-09-15
Accepted
2016-09-15 16:58:12
Documents
4
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 6-K sept2016egmproxy.htm 6-K 310239
2 debrauw2.jpg GRAPHIC 7687
3 qgennewheaderlogoa09.jpg GRAPHIC 11495
4 qlogoforproxy.jpg GRAPHIC 7377
  Complete submission text file 0001015820-16-000077.txt   347012
Mailing Address HULSTERWEG 82 PL VENLO P7 5912
Business Address HULSTERWEG 82 PL VENLO P7 5912 31-77-35566-00
QIAGEN NV (Filer) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-28564 | Film No.: 161887658
SIC: 2836 Biological Products, (No Diagnostic Substances)